165 related articles for article (PubMed ID: 14976351)
1. Evaluation of xenobiotic N- and S-oxidation by variant flavin-containing monooxygenase 1 (FMO1) enzymes.
Furnes B; Schlenk D
Toxicol Sci; 2004 Apr; 78(2):196-203. PubMed ID: 14976351
[TBL] [Abstract][Full Text] [Related]
2. Prochiral sulfoxidation as a probe for multiple forms of the microsomal flavin-containing monooxygenase: studies with rabbit FMO1, FMO2, FMO3, and FMO5 expressed in Escherichia coli.
Rettie AE; Lawton MP; Sadeque AJ; Meier GP; Philpot RM
Arch Biochem Biophys; 1994 Jun; 311(2):369-77. PubMed ID: 8203899
[TBL] [Abstract][Full Text] [Related]
3. Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.
Shimizu M; Yano H; Nagashima S; Murayama N; Zhang J; Cashman JR; Yamazaki H
Drug Metab Dispos; 2007 Mar; 35(3):328-30. PubMed ID: 17142560
[TBL] [Abstract][Full Text] [Related]
4. Investigation of structure and function of a catalytically efficient variant of the human flavin-containing monooxygenase form 3.
Borbás T; Zhang J; Cerny MA; Likó I; Cashman JR
Drug Metab Dispos; 2006 Dec; 34(12):1995-2002. PubMed ID: 16985102
[TBL] [Abstract][Full Text] [Related]
5. Unique monooxygenation pattern indicates novel flavin-containing monooxygenase in liver of rainbow trout.
Schlenk D; Yeung C; Rettie A
Mar Environ Res; 2004; 58(2-5):499-503. PubMed ID: 15178073
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamate, by flavin monooxygenase in human renal microsomes.
Pike MG; Mays DC; Macomber DW; Lipsky JJ
Drug Metab Dispos; 2001 Feb; 29(2):127-32. PubMed ID: 11159801
[TBL] [Abstract][Full Text] [Related]
7. Extrahepatic metabolism of carbamate and organophosphate thioether compounds by the flavin-containing monooxygenase and cytochrome P450 systems.
Furnes B; Schlenk D
Drug Metab Dispos; 2005 Feb; 33(2):214-8. PubMed ID: 15547051
[TBL] [Abstract][Full Text] [Related]
8. Baculovirus-mediated expression and purification of human FMO3: catalytic, immunochemical, and structural characterization.
Haining RL; Hunter AP; Sadeque AJ; Philpot RM; Rettie AE
Drug Metab Dispos; 1997 Jul; 25(7):790-7. PubMed ID: 9224773
[TBL] [Abstract][Full Text] [Related]
9. Prochiral sulfides as in vitro probes for multiple forms of the flavin-containing monooxygenase.
Rettie AE; Meier GP; Sadeque AJ
Chem Biol Interact; 1995 Apr; 96(1):3-15. PubMed ID: 7720102
[TBL] [Abstract][Full Text] [Related]
10. Size limits of thiocarbamides accepted as substrates by human flavin-containing monooxygenase 1.
Kim YM; Ziegler DM
Drug Metab Dispos; 2000 Aug; 28(8):1003-6. PubMed ID: 10901713
[TBL] [Abstract][Full Text] [Related]
11. Identification of amino acid residues associated with modulation of flavin-containing monooxygenase (FMO) activity by imipramine: structure/function studies with FMO1 from pig and rabbit.
Wyatt MK; Overby LH; Lawton MP; Philpot RM
Biochemistry; 1998 Apr; 37(17):5930-8. PubMed ID: 9558327
[TBL] [Abstract][Full Text] [Related]
12. Flavin-containing monooxygenase 1-catalysed N,N-dimethylamphetamine N-oxidation.
Lee SK; Kang MJ; Jin C; In MK; Kim DH; Yoo HH
Xenobiotica; 2009 Sep; 39(9):680-6. PubMed ID: 19552509
[TBL] [Abstract][Full Text] [Related]
13. The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion.
Leoni C; Buratti FM; Testai E
Toxicol Appl Pharmacol; 2008 Dec; 233(2):343-52. PubMed ID: 18845175
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms.
Sadeque AJ; Eddy AC; Meier GP; Rettie AE
Drug Metab Dispos; 1992; 20(6):832-9. PubMed ID: 1362935
[TBL] [Abstract][Full Text] [Related]
15. Prochiral sulfoxidation as a probe for flavin-containing monooxygenases.
Yeung CK; Rettie AE
Methods Mol Biol; 2006; 320():163-72. PubMed ID: 16719389
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the methionine S-oxidase activity of rat liver and kidney microsomes: immunochemical and kinetic evidence for FMO3 being the major catalyst.
Krause RJ; Ripp SL; Sausen PJ; Overby LH; Philpot RM; Elfarra AA
Arch Biochem Biophys; 1996 Sep; 333(1):109-16. PubMed ID: 8806760
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of functional dog flavin-containing monooxygenase 3.
Lickteig AJ; Riley R; Melton RJ; Reitz BA; Fischer HD; Stevens JC
Drug Metab Dispos; 2009 Oct; 37(10):1987-90. PubMed ID: 19635782
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing mono-oxygenases: studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine.
Ripp SL; Overby LH; Philpot RM; Elfarra AA
Mol Pharmacol; 1997 Mar; 51(3):507-15. PubMed ID: 9058607
[TBL] [Abstract][Full Text] [Related]
19. Immunoquantitation of FMO1 in human liver, kidney, and intestine.
Yeung CK; Lang DH; Thummel KE; Rettie AE
Drug Metab Dispos; 2000 Sep; 28(9):1107-11. PubMed ID: 10950857
[TBL] [Abstract][Full Text] [Related]
20. S-oxidation of S-methyl-esonarimod by flavin-containing monooxygenases in human liver microsomes.
Ohmi N; Yoshida H; Endo H; Hasegawa M; Akimoto M; Higuchi S
Xenobiotica; 2003 Dec; 33(12):1221-31. PubMed ID: 14742144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
